Common Names

  • LAPd
  • lipoic acid-palladium complex
  • Palladium-alpha-lipoic acid complex

For Patients & Caregivers

Bottom Line: Polydox (PolyMVA) has not been shown to treat or prevent cancer, lupus, asthma, HIV, or any other medical condition.

Polydox is a product that contains lipoic acid, acetyl cysteine, palladium, B vitamins, and other ingredients. The inventor and promoters of Polydox make many claims for this product that are not supported by any scientific evidence. Some of the components of Polydox are antioxidants (alpha-lipoic acid and acetyl cysteine).

There is no scientific evidence to support the following claims:

  • To treat asthma
  • To treat cancer
  • To treat chronic fatigue syndrome
  • To treat HIV and AIDS
  • To treat psoriasis
  • To treat systemic lupus erythematosus (SLE)

Clinical trials have not been conducted to determine the safety or effectiveness of Polydox for any of the proposed uses.

Back to top

For Healthcare Professionals


Polydox is a synthetic product containing lipoic acid-palladium complex (LAPd) and B complex vitamins. Patients use it to treat cancer, HIV/AIDS, chronic fatigue syndrome, psoriasis, and other degenerative disorders. Studies done in animals indicate that Polydox has neuroprotective (3), radioproctective (4), antidiabetic (7) and antioxidant (5)(6) properties.
Polydox has not been evaluated in clinical trials.

  • Asthma
  • Cancer treatment
  • Chronic fatigue syndrome
  • HIV and AIDS
  • Psoriasis
  • Systemic lupus erythematosus (SLE)
  • Palladium α-lipoic acid complex (1:1) 3.72 × 10−2 mmol/L
  • Thiamine 2.17 × 10−3 mmol/L
  • N-acetyl cysteine 1.13 × 10−3 mmol/L
  • Riboflavin 4.62 × 10−4 mmol/L
  • N-formyl methionine 1.46 × 10−4 mmol/L
  • Cyanocobalamin (Vitamin B12) 1.37 × 10−4 mmol/L
  • Rhodium 1.34 × 10−4 mmol/L
  • Molybdenum 4.63 × 10−4 mmol/L
  • Ruthenium 1.42 × 10−5 mmol/L
  • Sodium chloride 2.64 × 10−1 mmol/L


The inventor of Polydox claims that it is a metalo-vitamin; with antioxidant activity capable of repairing damaged genes. Polydox is said to have DNA reductase and electro-active; properties that alter electron flow in cancer cells at the mitochondrial level, resulting in cytotoxicity. The manufacturer reports benefits for cancer patients such as increases in energy and appetite, reduction in cancer-related pain (1)(2). However, no independent scientific data support these claims. Studies in rats show palladium-alpha-lipoic acid complex protects the aging of myocardium by enhancing the Krebs cycle dehydrogenases and mitochondrial electron transport chain complexes (5). It increases the level of glutathione and reduces the level of lipid peroxidation (6)(7). Palladium-alpha-lipoic acid complex also protect against radiation-induced cellular damages in animals (4).

The manufacturer claims that Polydox distributes throughout the body to all sites, including adipose tissue and the central nervous system. No formal pharmacokinetics studies have been performed.

Polydox’s antioxidant activity may interfere with the actions of certain chemotherapeutic agents.

Human studies have not been conducted.

  1. Polymva. American Medicine and Research Center web site. Available at http://www.polymva.com. Accessed August 14, 2013.

  2. Garnett M. Palladium complexes and methods for using same in the treatment of tumors. Garnett McKeen Laboratory, Inc. US Patent #5,679,697. October 21, 1997.

  3. Antonawich FJ, Fiore SM, Welicky LM. Regulation of ischemic cell death by the lipoic acid-palladium complex, Poly MVA, in gerbils. Exp Neurol.2004 Sep;189(1):10-5.

  4. Ramachandran L, Krishnan CV, Nair CK. Radioprotection by alpha-lipoic acid palladium complex formulation (POLY-MVA) in mice. Cancer Biother Radiopharm. 2010 Aug;25(4):395-9.

Back to top
Back to top
Email your questions and comments to aboutherbs@mskcc.org.

Last Updated